Can we manipulate the ovary’s own metabolism to protect it from chemotherapy-induced damage?

Some chemotherapy treatments induce female infertility through accelerated ovarian ageing, including due to nicotinamide adenine dinucleotide (NAD) depletion. Using various mouse models, Ho et al (2024) demonstrate that exposure to two such chemotherapy drugs, cisplatin or doxorubicin, deplete ovarian NAD, with levels restored by administrating the exogenous NAD precursor nicotinamide mononucleotide, ameliorating the drugs’ damaging effects on fertility. Yes: A. Stefansdottir, A. Liugaila and N. Spears discuss the study from Ho et al, in this issue of EMBO Mol. Med., that shows that nicotinamide mononucleotide supplementation ameliorates chemotherapy-induced female infertility without impairing treatment efficacy in breast cancer mouse models.

Authors

Institutions

Publication Details

Journal
EMBO Molecular Medicine
Published
2024-09-03
DOI
https://doi.org/10.1038/s44321-024-00124-z
Citations
1
Primary Topic
Reproductive Biology and Fertility
Type
article
Field-Weighted Citation Impact
0.54
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can we manipulate the ovary’s own metabolism to protect it from chemotherapy-induced damage?

Norah Spears, Agnes Stefansdottir, Adomas Liugaila
1 citations
EMBO Molecular Medicine
Reproductive Biology and Fertility
0.54
article

Can we manipulate the ovary’s own metabolism to protect it from chemotherapy-induced damage?

Norah Spears, Agnes Stefansdottir, Adomas Liugaila
article en
1 citations

Abstract

Some chemotherapy treatments induce female infertility through accelerated ovarian ageing, including due to nicotinamide adenine dinucleotide (NAD) depletion. Using various mouse models, Ho et al (2024) demonstrate that exposure to two such chemotherapy drugs, cisplatin or doxorubicin, deplete ovarian NAD, with levels restored by administrating the exogenous NAD precursor nicotinamide mononucleotide, ameliorating the drugs’ damaging effects on fertility. Yes: A. Stefansdottir, A. Liugaila and N. Spears discuss the study from Ho et al, in this issue of EMBO Mol. Med., that shows that nicotinamide mononucleotide supplementation ameliorates chemotherapy-induced female infertility without impairing treatment efficacy in breast cancer mouse models.

EMBO Molecular MedicineVol. 16(10)
University of Edinburgh (GB)
Zero hunger
Openalex Percentile: Top 29%
Reproductive Biology and Fertility
0.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Can we manipulate the ovary’s own metabolism to protect it from chemotherapy-induced damage? — Norah Spears, Agnes Stefansdottir, et al. · EMBO Molecular Medicine (2024) | TGRS Research Map | TGRS